loadpatents
name:-0.024086952209473
name:-0.010251998901367
name:-0.0014820098876953
DANYSZ; Wojciech Patent Filings

DANYSZ; Wojciech

Patent Applications and Registrations

Patent applications and USPTO patent grants for DANYSZ; Wojciech.The latest application filed is for "methods and compositions for treating undesired implanted tissue filler".

Company Profile
1.11.23
  • DANYSZ; Wojciech - Nidderau DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods And Compositions For Treating Undesired Implanted Tissue Filler
App 20220218739 - DANYSZ; Wojciech ;   et al.
2022-07-14
Systems And Methods For Combined Cosmetic Treatment Of Cellulite With Ultrasound
App 20210093898 - Pooth; Rainer ;   et al.
2021-04-01
Interval therapy for the treatment of loss of eyesight in humans with glaucoma and other degenerative eye diseases
Grant 9,717,772 - Russ , et al. August 1, 2
2017-08-01
Interval Therapy For The Treatment Of Loss Of Eyesight In Humans With Glaucoma And Other Degenerative Eye Diseases
App 20160038558 - RUSS; Hermann ;   et al.
2016-02-11
Glycine B antagonist
Grant 8,288,549 - Henrich , et al. October 16, 2
2012-10-16
Pyrazolopyrimidines for treating CNS disorders
App 20110212956 - Danysz; Wojciech ;   et al.
2011-09-01
Glycine B Antagonist
App 20110190342 - Henrich; Markus ;   et al.
2011-08-04
Substituted pyrazolo[1,5-A]pyrimidines as metabotropic glutamate receptor modulators
Grant 7,985,753 - Danysz , et al. July 26, 2
2011-07-26
Substituted pyrazolo[1,5-a]pyrimidines as metabotropic glutamate receptor modulators
Grant 7,947,689 - Danysz , et al. May 24, 2
2011-05-24
1-Amino-alkyl-cyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists
App 20100298442 - Parsons; Christopher Graham Raphael ;   et al.
2010-11-25
Novel Combination Of Neramexane For Treatment Of Nerordegeneratie Disorders
App 20100190751 - Hanschmann; Angelika ;   et al.
2010-07-29
Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
Grant 7,598,384 - Jirgensons , et al. October 6, 2
2009-10-06
Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors
App 20090227582 - Kauss; Valerjans ;   et al.
2009-09-10
Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors
Grant 7,550,482 - Kauss , et al. June 23, 2
2009-06-23
1-Aminocyclohexane derivatives for the treatment of multiple sclerosis, emotional lability and pseudobulbar affect
App 20090081259 - Jonas; Jeffrey ;   et al.
2009-03-26
Pyrazolopyrimidines, a process for their preparation and their use as medicine
App 20080039476 - Danysz; Wojciech ;   et al.
2008-02-14
Substituted pyrazolopyrimidines, a process for their preparation and their use as medicine
App 20080039458 - Danysz; Wojciech ;   et al.
2008-02-14
Pyrazolopyrimidines, a process for their preparation and their use as medicine
App 20080032998 - Danysz; Wojciech ;   et al.
2008-02-07
Metabotropic glutamate receptor modulators
App 20070299113 - Kalvinsh; Ivars ;   et al.
2007-12-27
Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists
App 20070185151 - Parsons; Christopher Graham Raphael ;   et al.
2007-08-09
Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT.sub.3, and neuronal nicotinic receptor antagonists
Grant 7,238,703 - Parsons , et al. July 3, 2
2007-07-03
1-Amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists
App 20070105961 - Parsons; Christopher Graham Raphael ;   et al.
2007-05-10
Cyclic and acyclic propenones for treating CNS disorders
App 20060074083 - Kalvinsh; Ivars ;   et al.
2006-04-06
Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists
Grant 7,022,729 - Parsons , et al. April 4, 2
2006-04-04
Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists
App 20060019982 - Parsons; Christopher Graham Raphael ;   et al.
2006-01-26
Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists
App 20060019983 - Parsons; Christopher Graham Raphael ;   et al.
2006-01-26
Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors
App 20060004001 - Jirgensons; Aigars ;   et al.
2006-01-05
Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors
App 20050288284 - Jirgensons, Aigars ;   et al.
2005-12-29
Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
App 20050197361 - Jirgensons, Aigars ;   et al.
2005-09-08
Unsaturated 1-amino-alkylcyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists
Grant 6,828,462 - Henrich , et al. December 7, 2
2004-12-07
Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists
App 20040034055 - Parsons, Christopher Graham Raphael ;   et al.
2004-02-19
Unsaturated 1-Amino-alkylcyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists
App 20030166634 - Henrich, Markus ;   et al.
2003-09-04
1-Amino-alkylcyclohexane NMDA receptor antagonists
Grant 6,034,134 - Gold , et al. March 7, 2
2000-03-07
Pyrido-phtalazin diones and their use against neurological disorders associated with excitotoxicity and malfunctioning of glutamatergic neurotransmission
Grant 5,776,935 - Danysz , et al. July 7, 1
1998-07-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed